108 related articles for article (PubMed ID: 34233924)
41. Complex I activity in hypoxia: implications for oncometabolism.
Chinopoulos C
Biochem Soc Trans; 2024 Apr; 52(2):529-538. PubMed ID: 38526218
[TBL] [Abstract][Full Text] [Related]
42. Targeting 2-oxoglutarate dehydrogenase for cancer treatment.
Chang LC; Chiang SK; Chen SE; Hung MC
Am J Cancer Res; 2022; 12(4):1436-1455. PubMed ID: 35530286
[TBL] [Abstract][Full Text] [Related]
43. Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma.
Anderson NM; Qin X; Finan JM; Lam A; Athoe J; Missiaen R; Skuli N; Kennedy A; Saini AS; Tao T; Zhu S; Nissim I; Look AT; Qing G; Simon MC; Feng H
Cancer Res; 2021 Sep; 81(17):4417-4430. PubMed ID: 34233924
[TBL] [Abstract][Full Text] [Related]
44. The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis.
Anderson NM; Li D; Peng HL; Laroche FJ; Mansour MR; Gjini E; Aioub M; Helman DJ; Roderick JE; Cheng T; Harrold I; Samaha Y; Meng L; Amsterdam A; Neuberg DS; Denton TT; Sanda T; Kelliher MA; Singh A; Look AT; Feng H
Leukemia; 2016 Jun; 30(6):1365-74. PubMed ID: 26876595
[TBL] [Abstract][Full Text] [Related]
45. DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer.
Shen N; Korm S; Karantanos T; Li D; Zhang X; Ritou E; Xu H; Lam A; English J; Zong WX; Liu CT; Shirihai O; Feng H
Commun Biol; 2021 Nov; 4(1):1289. PubMed ID: 34785772
[TBL] [Abstract][Full Text] [Related]
46. Defective function of α-ketoglutarate dehydrogenase exacerbates mitochondrial ATP deficits during complex I deficiency.
Piroli GG; Manuel AM; McCain RS; Smith HH; Ozohanics O; Mellid S; Cox JH; Cotham WE; Walla MD; Cascón A; Ambrus A; Frizzell N
Redox Biol; 2023 Nov; 67():102932. PubMed ID: 37883842
[TBL] [Abstract][Full Text] [Related]
47. Candidate drugs associated with sensitivity of cancer cell lines with
Kuhn C; Boeschen M; Philip M; Schöneberg T; Thor D; Horn S
Oncotarget; 2023 Jan; 14():14-20. PubMed ID: 36634214
[TBL] [Abstract][Full Text] [Related]
48. Mutagenesis of conserved active site residues of dihydrolipoamide succinyltransferase enhances the accumulation of α-ketoglutarate in Yarrowia lipolytica.
Guo H; Madzak C; Du G; Zhou J
Appl Microbiol Biotechnol; 2016 Jan; 100(2):649-59. PubMed ID: 26428234
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing.
Davis RT; Blake K; Ma D; Gabra MBI; Hernandez GA; Phung AT; Yang Y; Maurer D; Lefebvre AEYT; Alshetaiwi H; Xiao Z; Liu J; Locasale JW; Digman MA; Mjolsness E; Kong M; Werb Z; Lawson DA
Nat Cell Biol; 2020 Mar; 22(3):310-320. PubMed ID: 32144411
[TBL] [Abstract][Full Text] [Related]
50. MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma.
Oliynyk G; Ruiz-Pérez MV; Sainero-Alcolado L; Dzieran J; Zirath H; Gallart-Ayala H; Wheelock CE; Johansson HJ; Nilsson R; Lehtiö J; Arsenian-Henriksson M
iScience; 2019 Nov; 21():188-204. PubMed ID: 31670074
[TBL] [Abstract][Full Text] [Related]
51. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
Vashisht Gopal YN; Gammon S; Prasad R; Knighton B; Pisaneschi F; Roszik J; Feng N; Johnson S; Pramanik S; Sudderth J; Sui D; Hudgens C; Fischer GM; Deng W; Reuben A; Peng W; Wang J; McQuade JL; Tetzlaff MT; Di Francesco ME; Marszalek J; Piwnica-Worms D; DeBerardinis RJ; Davies MA
Clin Cancer Res; 2019 Nov; 25(21):6429-6442. PubMed ID: 31439581
[TBL] [Abstract][Full Text] [Related]
52. Metabolic Reprogramming by MYCN Confers Dependence on the Serine-Glycine-One-Carbon Biosynthetic Pathway.
Xia Y; Ye B; Ding J; Yu Y; Alptekin A; Thangaraju M; Prasad PD; Ding ZC; Park EJ; Choi JH; Gao B; Fiehn O; Yan C; Dong Z; Zha Y; Ding HF
Cancer Res; 2019 Aug; 79(15):3837-3850. PubMed ID: 31088832
[No Abstract] [Full Text] [Related]
53. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.
Zhang L; Yao Y; Zhang S; Liu Y; Guo H; Ahmed M; Bell T; Zhang H; Han G; Lorence E; Badillo M; Zhou S; Sun Y; Di Francesco ME; Feng N; Haun R; Lan R; Mackintosh SG; Mao X; Song X; Zhang J; Pham LV; Lorenzi PL; Marszalek J; Heffernan T; Draetta G; Jones P; Futreal A; Nomie K; Wang L; Wang M
Sci Transl Med; 2019 May; 11(491):. PubMed ID: 31068440
[TBL] [Abstract][Full Text] [Related]
54. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate.
Sica V; Bravo-San Pedro JM; Izzo V; Pol J; Pierredon S; Enot D; Durand S; Bossut N; Chery A; Souquere S; Pierron G; Vartholomaiou E; Zamzami N; Soussi T; Sauvat A; Mondragón L; Kepp O; Galluzzi L; Martinou JC; Hess-Stumpp H; Ziegelbauer K; Kroemer G; Maiuri MC
Cell Rep; 2019 Apr; 27(3):820-834.e9. PubMed ID: 30995479
[TBL] [Abstract][Full Text] [Related]
55. Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
Remacha L; Pirman D; Mahoney CE; Coloma J; Calsina B; Currás-Freixes M; Letón R; Torres-Pérez R; Richter S; Pita G; Herráez B; Cianchetta G; Honrado E; Maestre L; Urioste M; Aller J; García-Uriarte Ó; Gálvez MÁ; Luque RM; Lahera M; Moreno-Rengel C; Eisenhofer G; Montero-Conde C; Rodríguez-Antona C; Llorca Ó; Smolen GA; Robledo M; Cascón A
Am J Hum Genet; 2019 Apr; 104(4):651-664. PubMed ID: 30929736
[TBL] [Abstract][Full Text] [Related]
56. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Fischer GM; Jalali A; Kircher DA; Lee WC; McQuade JL; Haydu LE; Joon AY; Reuben A; de Macedo MP; Carapeto FCL; Yang C; Srivastava A; Ambati CR; Sreekumar A; Hudgens CW; Knighton B; Deng W; Ferguson SD; Tawbi HA; Glitza IC; Gershenwald JE; Vashisht Gopal YN; Hwu P; Huse JT; Wargo JA; Futreal PA; Putluri N; Lazar AJ; DeBerardinis RJ; Marszalek JR; Zhang J; Holmen SL; Tetzlaff MT; Davies MA
Cancer Discov; 2019 May; 9(5):628-645. PubMed ID: 30787016
[TBL] [Abstract][Full Text] [Related]
57. Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance.
Hirpara J; Eu JQ; Tan JKM; Wong AL; Clement MV; Kong LR; Ohi N; Tsunoda T; Qu J; Goh BC; Pervaiz S
Redox Biol; 2019 Jul; 25():101076. PubMed ID: 30642723
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
